BiotechTube
Home/Mwyngil Therapeutics/Claudia Filozof MD PhD
CF

Claudia Filozof MD PhD

Head of Clinical Development (interim)

Mwyngil Therapeutics

Therapeutic Areas

ObesityChronic Kidney DiseaseInflammatory DiseasesNeurodegenerationCardiovascular Disease

Mwyngil Therapeutics Pipeline

DrugIndicationPhase
MW-504Obesity, Chronic Kidney DiseasePreclinical
MW-313Chronic Kidney Disease, Cardiovascular DiseasePreclinical
MW-401Obesity, Chronic Kidney DiseasePreclinical

Leadership Team at Mwyngil Therapeutics

NS
Nikolay Savchuk PhD
CEO
VK
Vasily Kazey PhD
Head of Pharmacology
AK
Alexander Khvat PhD
Head of Medicinal Chemistry
BR
Boris Rogovoy PhD
Head of Chemistry
SM
Steph Mowery PhD
Head of Biology
SN
Srini Natala PhD
Lead Medicinal Chemistry
RK
Ruben Karapetyan PhD
Head of Development
View full Mwyngil Therapeutics profile